Search results for " polysaccharide"

showing 10 items of 30 documents

Typhoid Fever

2008

Typhoid fever continues to be a serious public health problem, with approximately 22. million cases and more than 200. 000 deaths globally. The disease is most often acquired by ingestion of food or water contaminated by the feces and less frequently by urine or vomitus of patients and carriers. Prolonged low-grade fever, headache, dry cough, alterations of bowel habits, coated tongue, and rose spots are the typical clinical features. Definitive diagnosis requires the isolation of Salmonella enterica serovar Typhi. Supportive serological tests are also used. First-choice antibiotic treatment includes fluoroquinolones or third-generation cephalosporins and reduces the mortality rate from 20%…

0301 basic medicine030106 microbiologyCephalosporinVi polysaccharide vaccineEnteric feverPeyer's patcheRose spotSalmonella typhiBlood cultureWaterborne03 medical and health sciencesTy21a0302 clinical medicineFluoroquinoloneTyphoid030212 general & internal medicineAgglutination testTyphoid FeverTyphoid fever
researchProduct

Structural characterization of polysaccharides of a productive strain of the culinary-medicinal king oyster mushroom, pleurotus eryngii (Agaricomycet…

2018

A preliminary biological investigation of the dry basidiomata of strain C-142-c of Pleurotus eryngii has shown significant antioxidant activity. Two different polysaccharides (PEPS-A1 and PEPS-A2) were isolated from the cultivated edible mushroom, P. eryngii C-142-c strain. Based on acid hydrolysis, methylation analysis, and nuclear magnetic resonance experiments (1H, 13C, distortionless enhancement by polarization transfer, double quantum filtered correlation spectroscopy, total correlation spectroscopy, nuclear Overhauser effect spectroscopy, heteronuclear singlequantum correlation spectroscopy, and heteronuclear multiple-bond correlation spectroscopy), the structures of the repeating uni…

0301 basic medicineAntioxidantMedicinal mushroommedicine.medical_treatmenteducationPleurotus eryngii; polysaccharides; antioxidant activity; MTT assay; medicinal mushroomspolysaccharidesantioxidant activityNuclear Overhauser effectPolysaccharidePleurotusApplied Microbiology and BiotechnologyPleurotus eryngii03 medical and health sciencesAntioxidant activityDrug DiscoverymedicinePleurotus eryngiiViability assayFood sciencePolysaccharidechemistry.chemical_classificationPharmacologyMushroomMTT assaybiologyChemistrymedicinal mushroomsDrug Discovery3003 Pharmaceutical ScienceFungal Polysaccharidesbiology.organism_classificationFungal PolysaccharideEdible mushroom030104 developmental biologyItalypolysaccharidecardiovascular systemPleurotuTwo-dimensional nuclear magnetic resonance spectroscopycirculatory and respiratory physiology
researchProduct

Specificity of human natural antibodies referred to as anti-Tn

2020

International audience; To understand the role of human natural IgM known as antibodies against the carbohydrate epitope Tn, the antibodies were isolated using GalNAcα−Sepharose affinity chromatography, and their specificity was profiled using microarrays (a glycan array printed with oligosaccharides and bacterial polysaccharides, as well as a glycopeptide array), flow cytometry, and inhibition ELISA. The antibodies bound a restricted number of GalNAcα-terminated oligosaccharides better than the parent monosaccharide, e.g., 6-O-Su-GalNAcα and GalNAcα1−3Galβ1−3(4)GlcNAcβ. The binding with several bacterial polysaccharides that have no structural resemblance to the affinity ligand GalNAcα was…

0301 basic medicineGlycanGlycansImmunologyTn antigenAntibody Affinity[SDV.CAN]Life Sciences [q-bio]/CancerAnti-Glycan antibodiesEpitopeAntigen-Antibody ReactionsEpitopesJurkat Cells03 medical and health sciences0302 clinical medicineAffinity chromatography[SDV.CAN] Life Sciences [q-bio]/CancerAntibody SpecificityNeoplasmsTn antigenHumansAntigens Tumor-Associated CarbohydrateAmino Acid SequenceMolecular BiologyPeptide sequenceCancerbiologyChemistryBacterial polysaccharideImmunity Innate3. Good health030104 developmental biologyCarbohydrate SequenceImmunoglobulin MBiochemistryNatural antibodiesbiology.proteinParatopeAntibody030215 immunology
researchProduct

Randomized Study of Early versus Late Immunization with Pneumococcal Conjugate Vaccine after Allogeneic Stem Cell Transplantation

2009

BACKGROUND: Invasive pneumococcal disease is a life-threatening complication after allogeneic stem cell transplantation, and at least 20% of cases occur within 1 year after transplantation. The 23-valent pneumococcal polysaccharide vaccine (PPV23) has limited efficacy, especially during the first year after transplantation. The immune response to the conjugated vaccines is expected to be better than that to the polysaccharide vaccine, but the optimal timing of vaccination is not defined. Our objective was to show that a 7-valent pneumococcal conjugate vaccine (PCV7; Prevnar) was not inferior when first given 3 months after transplantation, compared with when first given 9 months after trans…

AdultMaleMicrobiology (medical)Pediatricsmedicine.medical_specialtyHeptavalent Pneumococcal Conjugate VaccineTime FactorsAdolescentmedicine.medical_treatmentImmunization SecondaryHematopoietic stem cell transplantationPneumococcal conjugate vaccinePneumococcal VaccinesYoung AdultHeptavalent Pneumococcal Conjugate VaccineHumansMedicineChildImmunization Schedulebusiness.industryPneumococcal 7-Valent Conjugate VaccineMiddle AgedAntibodies BacterialPneumococcal polysaccharide vaccineEuropeVaccinationTransplantationInfectious DiseasesImmunizationImmunologyFemalebusinessImmunosuppressive AgentsStem Cell Transplantationmedicine.drugClinical Infectious Diseases
researchProduct

Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza dur…

2013

Background: Since influenza predisposes to bacterial pneumonia caused by Streptococcus pneumoniae, studies have suggested that pneumococcal vaccination might reduce its occurrence during pandemics. We assessed the effectiveness of pneumococcal polysaccharide vaccination alone and in combination with influenza vaccination in preventing influenza hospitalization during the 2009–2010 pandemic wave and 2010–2011 influenza epidemic. Methods: We conducted a multicenter case-control study in 36 Spanish hospitals. We selected patients aged ≥ 18 y hospitalized with confirmed influenza and two hospitalized controls per case, matched according to age, date of hospitalization and province of residence.…

AdultMalemedicine.medical_specialtyAdolescentInfluenza vaccineImmunologymedicine.disease_causePneumococcal VaccinesYoung AdultInternal medicineStreptococcus pneumoniaePandemicInfluenza HumanmedicineImmunology and AllergyHumansYoung adultAgedPharmacologyAged 80 and overbusiness.industryBacterial pneumoniaCase-control studyvirus diseasesMiddle AgedPneumonia Pneumococcalmedicine.diseasePneumococcal polysaccharide vaccineVaccinationHospitalizationInfluenza VaccinesSpainCase-Control StudiesImmunologyCosts and Cost AnalysisFemalebusinessResearch Paper
researchProduct

Drying enhances immunoactivity of spent brewer's yeast cell wall β-D-glucans.

2015

Due to immunological activity, microbial cell wall polysaccharides are defined as 'biological response modifiers' (BRM). Cell walls of spent brewer's yeast also have some BRM activity. However, up to date there is no consensus on the use of spent brewer's yeast D-glucan as specific BRM in humans or animals. The aim of this paper is to demonstrate the potential of spent brewer's yeast β-D-glucans as BRM, and drying as an efficient pretreatment to increase β-D-glucan's immunogenic activity. Our results revealed that drying does not change spent brewer's yeast biomass carbohydrate content as well as the chemical structure of purified β-D-glucan. However, drying increased purified β-D-glucan TN…

Carbohydrate contentbeta-GlucansChemical structureBioengineeringSaccharomyces cerevisiaeBiologyPolysaccharideApplied Microbiology and BiotechnologyCell wallchemistry.chemical_compoundCell WallSpectroscopy Fourier Transform InfraredAnimalsDesiccationCells Culturedchemistry.chemical_classificationMice Inbred ICRExtraction (chemistry)Fungal PolysaccharidesGeneral MedicineYeastPleurancarbohydrates (lipids)stomatognathic diseaseschemistryBiochemistryYeast biomassMacrophages PeritonealBiotechnologyJournal of biotechnology
researchProduct

Polysaccharides from Pleurotus eryngii var. elaeoselini (Agaricomycetes), a New Potential Culinary-Medicinal Oyster Mushroom from Italy.

2020

Three water-soluble glucans (PELPS-A1, PELPS-A2, and PELPS-A3) purified from the hot water extract of the basidiomata of an edible mushroom Pleurotus eryngii var. elaeoselini by chromatography on DEAE-cellulose 32 and Sephadex G-100 column were found to consist of only D-glucose as monosaccharide constituent. Structural investigation was carried out by acid hydrolysis, periodate oxidation, and NMR experiments (1H-NMR, 13C-NMR, DQF-COSY, TOCSY, ROESY, HMQC, and HMBC). On the basis of these experiments, the structures of the repeating unit of the three isolated polysaccharides were established as follows: (1) PELPS-A1: {[→3)-α-D-Glcp-(1→]3→4)-α-D-Glcp-(1→2)-α-D-Glcp-(1→6)-α-D-Glcp-(1[→6)-β-D-…

DPPH assayAntioxidantMagnetic Resonance SpectroscopyDPPHmedicine.medical_treatmentpolysaccharidesantioxidant activityPolysaccharidePleurotusApplied Microbiology and BiotechnologyAntioxidantschemistry.chemical_compoundDrug Discoverymedicinehydroxyl radical scavenging activityMonosaccharidePleurotus eryngiiPleurotus eryngii var. elaoseliniGlucansPharmacologychemistry.chemical_classificationMushroombiologymedicinal mushroomsHydroxyl Radicalbiology.organism_classificationPleurotus eryngii var. elaoselini polysaccharides antioxidant activity DPPH assay hydroxyl radical scavenging activity medicinal mushroomsEdible mushroomchemistrySettore BIO/03 - Botanica Ambientale E ApplicataHydroxyl radicalNuclear chemistryInternational journal of medicinal mushrooms
researchProduct

The Antiviral Activity of Bacterial, Fungal, and Algal Polysaccharides as Bioactive Ingredients: Potential Uses for Enhancing Immune Systems and Prev…

2021

Viral infections may cause serious human diseases. For instance, the recent appearance of the novel virus, SARS-CoV-2, causing COVID-19, has spread globally and is a serious public health concern. The consumption of healthy, proper, functional, and nutrient-rich foods has an important role in enhancing an individual's immune system and preventing viral infections. Several polysaccharides from natural sources such as algae, bacteria, and fungi have been considered as generally recognized as safe (GRAS) by the US Food and Drug Administration. They are safe, low-toxicity, biodegradable, and have biological activities. In this review, the bioactive polysaccharides derived from various microorga…

Endocrinology Diabetes and MetabolismMicroorganismReviewPolysaccharideimmunomodulationsulfated polysaccharidesVirusMicrobiologyImmune systemGenerally recognized as safeTX341-641Nutritionchemistry.chemical_classificationNutrition and DieteticsbiologySARS-CoV-2Nutrition. Foods and food supplyCOVID-19Antimicrobialbiology.organism_classificationViruschemistryDrug deliveryantiviral activityBacteriaFood ScienceFrontiers in Nutrition
researchProduct

Immunohistochemical localization of polysialic acid in tissue sections: differential binding to polynucleotides and DNA of a murine IgG and a human I…

1990

For immunolocalization of alpha(2-8)-linked polysialic acid, which forms part of the neural cell adhesion molecule (N-CAM), two monoclonal antibodies, MAb735 and IgMNOV, were employed. Both antibodies have previously been shown to bind the extremely low immunogenic capsular polysaccharide of group B meningococci, which also consists of alpha(2-8) polysialic acid, but not to other, even closely related forms of polysialic acid. Despite the identical polysaccharide specificity of these two MAb, we observed marked differences of the staining pattern in tissue sections. We showed that these differences in immunostaining were due to the crossreactivity of IgMNOV with polynucleotides and DNA. MA…

Histologymedicine.drug_classCell Adhesion Molecules NeuronalPolynucleotidesAntibody AffinityEnzyme-Linked Immunosorbent AssayMonoclonal antibodyBinding CompetitiveImmunoglobulin Gchemistry.chemical_compoundMiceAntigenmedicineAnimalsHumansAntigensBrain ChemistrybiologyStaining and LabelingPolysialic acidBacterial polysaccharideAntibodies MonoclonalDNAMolecular biologyImmunohistochemistrySialic acidBiochemistrychemistryLiverImmunoglobulin Gbiology.proteinSialic AcidsNeural cell adhesion moleculeAnatomyDNA ProbesImmunostainingThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
researchProduct

Green Nanocomposites-Based on PLA and Natural Organic Fillers

2017

Over the past decades, many efforts have been carried out for the development of novel green nanocomposites based on biopolymers and natural organic nanofillers. Indeed, these nanocomposites could replace some oil-derived polymers and thus helping to overcome environmental problems. In this regard, poly (lactic acid) (PLA) as matrix and polysaccharide nanocrystals (cellulose, chitin, and starch) as bio-based nanoreinforcements are the most promising components to obtain high-performance green nanocomposites. This chapter covers the basic features of PLA and polysaccharide nanocrystals derived from biomass-based raw materials such as cellulose, chitin, and starch. In particular, this chapter…

Materials scienceNanocompositeChemical engineering02 engineering and technology010402 general chemistry021001 nanoscience & nanotechnology0210 nano-technology01 natural sciencesNatural (archaeology)Poly (lactic acid) (PLA) nanocomposites polysaccharide nanocrystals cellulose nanocrystals (CNCs) chitin nanocrystals (ChNCs) starch nanocrystals (SNCs)0104 chemical sciences
researchProduct